Bell Iris R, Koithan Mary, Brooks Audrey J
Department of Family and Community Medicine, The University of Arizona College of Medicine, Tucson, AZ USA.
Homeopathy. 2013 Jan;102(1):66-81. doi: 10.1016/j.homp.2012.10.005.
Key concepts of the Nanoparticle-Allostatic Cross-Adaptation-Sensitization (NPCAS) Model for the action of homeopathic remedies in living systems include source nanoparticles as low level environmental stressors, heterotypic hormesis, cross-adaptation, allostasis (stress response network), time-dependent sensitization with endogenous amplification and bidirectional change, and self-organizing complex adaptive systems. The model accommodates the requirement for measurable physical agents in the remedy (source nanoparticles and/or source adsorbed to silica nanoparticles). Hormetic adaptive responses in the organism, triggered by nanoparticles; bipolar, metaplastic change, dependent on the history of the organism. Clinical matching of the patient's symptom picture, including modalities, to the symptom pattern that the source material can cause (cross-adaptation and cross-sensitization). Evidence for nanoparticle-related quantum macro-entanglement in homeopathic pathogenetic trials. This paper examines research implications of the model, discussing the following hypotheses: Variability in nanoparticle size, morphology, and aggregation affects remedy properties and reproducibility of findings. Homeopathic remedies modulate adaptive allostatic responses, with multiple dynamic short- and long-term effects. Simillimum remedy nanoparticles, as novel mild stressors corresponding to the organism's dysfunction initiate time-dependent cross-sensitization, reversing the direction of dysfunctional reactivity to environmental stressors. The NPCAS model suggests a way forward for systematic research on homeopathy. The central proposition is that homeopathic treatment is a form of nanomedicine acting by modulation of endogenous adaptation and metaplastic amplification processes in the organism to enhance long-term systemic resilience and health.
顺势疗法药物在生命系统中作用的纳米颗粒 - 稳态交叉适应 - 致敏(NPCAS)模型的关键概念包括作为低水平环境应激源的源纳米颗粒、异型兴奋效应、交叉适应、稳态(应激反应网络)、具有内源性放大和双向变化的时间依赖性致敏,以及自组织复杂适应系统。该模型符合药物中可测量物理因子的要求(源纳米颗粒和/或吸附在二氧化硅纳米颗粒上的源物质)。纳米颗粒引发生物体中的兴奋适应性反应;双相、化生变化,取决于生物体的历史。将患者症状表现(包括症状特征)与源物质可引发的症状模式进行临床匹配(交叉适应和交叉致敏)。顺势疗法致病试验中与纳米颗粒相关的量子宏观纠缠的证据。本文探讨了该模型的研究意义,讨论了以下假设:纳米颗粒大小、形态和聚集的变异性会影响药物特性和研究结果的可重复性。顺势疗法药物调节适应性稳态反应,具有多种动态短期和长期效应。最相似药物纳米颗粒作为与生物体功能障碍相对应的新型轻度应激源,引发时间依赖性交叉致敏,逆转对环境应激源功能障碍反应的方向。NPCAS模型为顺势疗法的系统研究指明了方向。核心观点是顺势疗法治疗是一种纳米医学形式,通过调节生物体内的内源性适应和化生放大过程来增强长期的全身恢复力和健康。